Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset - 17/08/16
Doi : 10.1016/j.jaad.2016.04.045
George Denny, BS b, Milan J. Anadkat, MD a, b, ⁎ 
a Division of Dermatology, St Louis, Missouri
b Washington University School of Medicine, St Louis, Missouri
∗Correspondence to: Milan J. Anadkat, MD, Division of Dermatology, Washington University School of Medicine, 660 S Euclid Ave, Campus Box 8123, St Louis, MO 63110Division of DermatologyWashington University School of Medicine660 S Euclid Ave, Campus Box 8123St LouisMO63110
| Supported by the Washington University Institute of Clinical and Translational Sciences grant TL1 TR000449 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
| Disclosure: Dr Anadkat has received honoraria as a speaker and/or consultant from AstraZeneca, Bristol-Myers Squibb, Eisai, ImClone, and Therakos. He has also served as an investigator for Hana Biosciences and Xoma. Mr Denny has served as a consultant for Epharmix. |
© 2016
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 75 - N° 3
P. 632-634 - septembre 2016 Retour au numéro
Article précédent
- Reducing outpatient dermatology clinic wait times in a safety net health system in Dallas, Texas
- Jack C. O’Brien, Benjamin F. Chong
- Clinical and trichoscopic characteristics of temporal triangular alopecia: A multicenter study
- Pablo Fernández-Crehuet, Sergio Vaño-Galván, Antonio Martorell-Calatayud, Salvador Arias-Santiago, Ramón Grimalt, Francisco M. Camacho-Martínez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?